Von Willebrand disease is one of the most common bleeding disorders that affects both men and women equally. However, the diagnosis of von Willebrand disease has often been challenging due to broad clinical presentation and variability in testing methods e.g. Ristocetin cofactor activity.
Today you will learn more about the laboratory investigation of von Willebrand disease, focusing on the different tests involved in the diagnosis. In his presentation our speaker will discuss the new guidelines for diagnosis and newer assays for von Willebrand factor activity.
Dr. John Mitsios, Medical Sciences Partner at Siemens Healthineers, will help you to:
- Describe the different stages of hemostasis
- Describe the first line testing for von Willebrand Disease
- Describe the second line testing for von Willebrand Disease
Speaker:
By clicking Submit you consent to the processing of your above given personal data by the Siemens Healthineers company referred to under Corporate Information and for the purpose described above. Further information concerning the processing of your data can be found in the Data Privacy Policy. You are aware that you can partially or completely revoke this consent at any time for the future. Please declare your revocation to the contact address given in the Corporate Information and sent it to us via the following e-mail address: dataprivacy.func@siemens-healthineers.com
